SMT: Clinical Trials

2 trials of SMT, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Terminated 1

Follow SMT: new trials by email Literature Review of SMT trials Research Report on SMT

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5%
SMT + PE-A 5%, Standard Medical Treatment - Acute-On-Chronic Liver Failure
Phase 3TerminatedInstituto Grifols, S.A.2742019-06-172026-06-04
Effects of Long-Term Administration of Human Albumin in Participants With Decompensated Cirrhosis and Ascites
Albutein 20%, SMT - Decompensated Cirrhosis and Ascites
Phase 3CompletedGrifols Therapeutics LLC4102018-07-242025-06-06

Conditions studied

Acute-On-Chronic Liver Failure (1)  ·  Ascites (1)

Sponsors

Grifols Therapeutics LLC (1)  ·  Instituto Grifols, S.A. (1)

Countries

Belgium (2)  ·  France (2)  ·  Germany (2)  ·  Italy (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Austria (1)  ·  Bosnia and Herzegovina (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Denmark (1)  ·  Hungary (1)  ·  Poland (1)  ·  Portugal (1)

Results publications

PMID 30905652

NIH funding

2016 (1)